Ferric Citrate in ESRD Pilot Project

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 11, 2017

Primary Completion Date

September 30, 2019

Study Completion Date

February 29, 2020

Conditions
End Stage Renal DiseaseChronic Kidney Diseases
Interventions
DRUG

Ferric Citrate

Doses can be adjusted as needed by 1 to 2 tablets up to a maximum of 12 tablets daily. Dose can be titrated at 1-week or longer intervals.

Trial Locations (2)

77004

Harris Health System - Riverside Dialysis Center, Houston

77021

US Renal Care- Scott Street, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Keryx Biopharmaceuticals

INDUSTRY

lead

Sreedhar Mandayam

OTHER